1996
DOI: 10.1016/0024-3205(96)00097-5
|View full text |Cite
|
Sign up to set email alerts
|

Extracts of ginkgo biloba leaves inhibit monoamine oxidase

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
55
0

Year Published

1998
1998
2012
2012

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 99 publications
(56 citation statements)
references
References 9 publications
1
55
0
Order By: Relevance
“…The decreased density of b-adrenoreceptors shown in this study might be due to down-regulation of receptors following an increase of biogenic monoamines and especially of noradrenaline. This suggestion is consistent with a blockade of monoamine neurotransmitter degradation due to inhibition of monoamine oxidase caused by Ginkgo biloba extracts (White et al 1996).…”
Section: Resultssupporting
confidence: 56%
“…The decreased density of b-adrenoreceptors shown in this study might be due to down-regulation of receptors following an increase of biogenic monoamines and especially of noradrenaline. This suggestion is consistent with a blockade of monoamine neurotransmitter degradation due to inhibition of monoamine oxidase caused by Ginkgo biloba extracts (White et al 1996).…”
Section: Resultssupporting
confidence: 56%
“…109 One in vitro study reported that compounds present in both dried and fresh Ginkgo leaves have monoamine oxidase (MAO) (both A and B) inhibitory activity 110 ; however, there is currently no evidence that G biloba extracts ingested in normal dosages by humans will inhibit MAO activity in the brain. Finally, there is evidence from animal studies that ginkolide B may have a neuroprotective effect in brain injury.…”
Section: Ginkgomentioning
confidence: 99%
“…Ginkgo biloba has been shown to have neuroprotective effects on brain neurons against oxidative stress induced by peroxidation in some recent studies (Maitra et al, 1995;Oyama et al, 1996;Ni et al, 1996;Hoyer et al, 1999). More recent evidence has shown that Ginkgo biloba also acts as an inhibitor of the monoamine metabolizing enzymes, monoamine oxidase A and B, which may also contribute to its free-radical scavenging and neuroprotective effects (White et al, 1996). In addition, evidence suggests that both acute and chronic doses of Ginkgo biloba may modulate the cholinergic system (Nathan, 2000), with direct effects on choline uptake and acetylcholine release (Kristofikova and Klaschka, 1997) and increases in cholinergic muscarinic receptors (Taylor, 1986).…”
Section: Introductionmentioning
confidence: 95%